SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-102801
Filing Date
2023-04-17
Accepted
2023-04-17 06:34:54
Documents
18
Period of Report
2023-04-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d481556d8k.htm   iXBRL 8-K 73014
2 EX-2.1 d481556dex21.htm EX-2.1 500037
3 EX-2.2 d481556dex22.htm EX-2.2 86380
4 EX-10.1 d481556dex101.htm EX-10.1 146456
5 EX-99.1 d481556dex991.htm EX-99.1 20635
9 GRAPHIC g481556g0417054659887.jpg GRAPHIC 2404
10 GRAPHIC g481556g63a11.jpg GRAPHIC 308448
  Complete submission text file 0001193125-23-102801.txt   1574415

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA stsa-20230411.xsd EX-101.SCH 2856
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE stsa-20230411_lab.xml EX-101.LAB 18737
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stsa-20230411_pre.xml EX-101.PRE 11711
12 EXTRACTED XBRL INSTANCE DOCUMENT d481556d8k_htm.xml XML 3465
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39041 | Film No.: 23822772
SIC: 2834 Pharmaceutical Preparations